Validating a novel microfluidic platform as an ex vivo tumour model for sarcoma drug discovery
Validating a novel microfluidic platform as an ex vivo tumour model for sarcoma drug discovery
验证新型微流体平台作为肉瘤药物发现的离体肿瘤模型
批准号：
486298
负责人：
Kamal Kousha
金额：
$1.27万
依托单位：
依托单位国家：
加拿大
项目类别：
Studentship Programs
财政年份：
2022
资助国家：
加拿大
项目状态：
已结题
起止时间：
2022-12-01 至 2023-12-01
中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Sarcomas are a rare group of mesenchymal cancers that routinely spread to other parts of the body. In these cases, the median survival rate of patients is very poor due to a low response rate to traditional systemic therapies. More recently, immunotherapy
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金
